STAT
SEPTEMBER 22, 2023
Yale and the VA agreed in 2003 to share royalties on patents with inventors from both institutions. When a comparable drug is not available, 29% turn to their pharmacy’s compounding services, while 6% look to another compounding pharmacy. Yale and professor John Krystal agreed to pay $1.5
pharmaphorum
MARCH 2, 2022
The term ‘psychedelic treatments’ incorporates a broad spectrum of different compounds, from LSD, psilocybin and DMT, to MDMA, ibogaine and ketamine. The latter compound has already been approved for treatment-resistance depression as the product Spravato (esketamine), after being developed by Janssen.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
OCTOBER 19, 2023
With alpha particles, you must be very careful how the drug is made to ensure that the compound remains stable between manufacturing and use. Following his graduate studies, Dr Hoppin was an Alexander von Humboldt Fellow at the Research Center Jülich, Center for Electronics in Germany from 2003 to 2005.
European Pharmaceutical Review
DECEMBER 21, 2022
Organic compounds are arguably the foundation of the pharmaceutical industry. All traditional small molecule pharmaceuticals include carbon building blocks” Organic compounds are arguably the foundation of the pharmaceutical industry. Org Process Res Dev 2020, 24, 10, 1996–2003. Shores BT, Sieg PE, Nicosia AT, et al.
RX Note
APRIL 16, 2023
Introduction Vitamins are chemically unrelated families of organic compounds that are essential in small amounts for normal metabolism. Because vitamins (with the exception of vitamin D 3 , vitamin K 2 and B 12 ) cannot be synthesized by humans , they need to be ingested in the diet to prevent disorders of metabolism.
PharmaShots
JUNE 28, 2023
Consistent with prior periods, Enbrel continued to lose market share, and this decline was compounded by a reduction in the growth rate of the rheumatology market as a result of COVID-19. Generally, these reviews are helpful when consumers research the product and read multiple reviews before buying it.
Pharmacy Times
JUNE 23, 2025
From 2003 to 2023, 943 drugs were approved through the 505(b)(2) pathway. As of January 1, 2023, CMS has begun issuing unique J-codes to 505(b)(2) drugs dating back to 2003. “In However, 505(b)(2) drugs have been available since the 1980s. “CMS
Expert insights. Personalized for you.
251 
Let's personalize your content